Anavex Life Sciences Corp (AVXL)

[falconer66a]

No TV Ads for Blarcamesine

...we will not need to advertise like others. Also, with respect to AD or PD or any other Neurological disease I think it [blarcamesine] will sell itself.

Each evening I watch the major network newscasts. I’ve noted that virtually every newscast has numerous ads for prescription pharmaceuticals. Curious, yes?

Patients have to have a prescription from a doctor to buy these expensive drugs. Viewers can’t just run down the street to a pharmacy and say, “Hey, I got that disease I saw in the TV ad last night. I wanna buy that drug. It’ll be good for me.”

In fact, the US is one of the only countries that allows drug companies to advertise their prescription drugs on broadcast media. No real sense to it.

I’m pretty accomplished in creating interesting and informative digital graphics, for science papers and presentations I give to public audiences on a number of science topics. So, when I watch the movie-like scenes in the big drug ads, I marvel that scrolling across the bottom of the screen, in smallish type, is the exhaustive list of side effects and warnings for the drug being peddled.

But what, do you suppose, would TV ads for blarcamesine say — not that there ever will be any?

“Ask your grandmother’s doctor to get grandma on blarcamesine! She’ll be able to sleep and won’t be so confused. Blarcamesine will dramatically slow, or even reverse the course of her Alzheimer’s. Blarcamesine NOW!”

Running at the bottom of the screen, in reasonably-sized type, “Although very safe, be sure to take blarcamesine before bed, to minimize any rare dizziness.” Unlike most other drugs, no warnings of any severe or even lethal side effects.

But, of course, after blarcamesine is approved and available to treat Alzheimer’s, no TV ads will be required. All Alzheimer’s stakeholders, physicians, patients, and everyone in the pharmaceuticals business, will quickly learn and know that the drug simply is safe, inexpensive, and profoundly therapeutic; the new and effective standard of care (SOC) Alzheimer’s therapy that all other drugs would need to match; but can’t.

Dr. Missling’s team is not anticipating the engagement of drug advertising contractors to put up expensive TV ads for blarcamesine. As mentioned, the drug will sell itself.